CN Stock MarketDetailed Quotes

002788 Luyan Pharma

Watchlist
  • 9.04
  • -0.11-1.20%
Market Closed Dec 13 15:00 CST
3.51BMarket Cap9.78P/E (TTM)

Luyan Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
4.32%15.41B
2.81%10.31B
6.08%5.14B
1.97%19.85B
3.15%14.78B
7.32%10.02B
4.40%4.84B
10.93%19.46B
10.16%14.32B
10.22%9.34B
Operating revenue
4.32%15.41B
2.81%10.31B
6.08%5.14B
1.97%19.85B
3.15%14.78B
7.32%10.02B
4.40%4.84B
10.93%19.46B
10.16%14.32B
10.22%9.34B
Other operating revenue
----
-6.47%24.82M
----
7.03%60.56M
----
3.13%26.54M
----
52.24%56.58M
----
89.66%25.73M
Total operating cost
4.26%15.05B
2.64%10.04B
6.07%5.02B
2.19%19.36B
3.36%14.44B
7.54%9.78B
4.38%4.73B
10.73%18.95B
10.16%13.97B
10.17%9.1B
Operating cost
4.34%14.28B
2.73%9.53B
6.22%4.76B
2.17%18.34B
3.39%13.69B
7.68%9.28B
4.22%4.48B
10.96%17.95B
10.30%13.24B
10.28%8.62B
Operating tax surcharges
12.99%34.07M
17.29%23.29M
10.78%11.04M
3.04%43.55M
2.34%30.16M
1.16%19.86M
9.95%9.96M
7.81%42.26M
-3.29%29.47M
0.50%19.63M
Operating expense
5.02%341.69M
2.79%224.48M
8.84%114.82M
2.07%441.71M
5.03%325.35M
7.49%218.38M
6.21%105.49M
14.09%432.77M
9.97%309.78M
9.88%203.18M
Administration expense
4.89%234.67M
1.79%154.21M
3.65%78.01M
3.51%309.28M
1.33%223.74M
4.31%151.49M
7.85%75.26M
-7.17%298.78M
-1.44%220.81M
0.19%145.23M
Financial expense
-6.99%155.39M
-6.81%103.16M
-8.91%52.73M
1.30%222.91M
0.77%167.06M
1.58%110.7M
8.13%57.89M
15.01%220.05M
19.33%165.79M
19.42%108.97M
-Interest expense (Financial expense)
1.29%152.95M
0.27%101.71M
-0.47%50.78M
1.71%222.85M
1.08%151M
3.24%101.44M
8.70%51.02M
15.15%219.1M
11.72%149.38M
13.22%98.25M
-Interest Income (Financial expense)
17.61%-3.01M
44.08%-2.1M
16.62%-1.04M
-33.27%-5.14M
11.67%-3.66M
-48.82%-3.75M
-34.98%-1.25M
25.53%-3.86M
17.04%-4.14M
-0.52%-2.52M
Research and development
28.23%3.64M
41.26%2.74M
58.31%1.22M
33.47%5.53M
-0.77%2.84M
38.41%1.94M
27.61%769.3K
39.51%4.15M
24.78%2.86M
-16.03%1.4M
Credit Impairment Loss
4.17%-17.52M
-35.85%-14.86M
-2.20%-12.28M
70.15%-14.71M
13.57%-18.28M
24.51%-10.94M
-17.29%-12.02M
-57.46%-49.3M
-2.77%-21.15M
-25.30%-14.49M
Asset Impairment Loss
49.98%-289.95K
227.46%418.83K
-426.72%-575.39K
17.53%-2.58M
88.66%-579.62K
92.46%-328.6K
95.94%-109.24K
55.64%-3.13M
-30.06%-5.11M
2.58%-4.36M
Other net revenue
-56.48%-25.44M
-140.57%-18.06M
-26.33%-14.81M
65.76%-17.53M
34.44%-16.25M
58.61%-7.51M
4.32%-11.73M
-67.33%-51.19M
-41.73%-24.79M
-23.70%-18.13M
Fair value change income
----
----
--0
----
----
----
--0
----
----
----
Invest income
-167.53%-12.98M
-459.42%-9.31M
-37.48%-3.55M
-75.66%-12.16M
-95.55%-4.85M
-17.43%-1.66M
-577.61%-2.58M
-224.12%-6.92M
-404.65%-2.48M
45.20%-1.42M
Net open hedge income
----
----
--0
----
----
----
--0
----
----
----
-Including: Investment income associates
-320.97%-3.22M
---2.45M
--0
-117.01%-154.29K
--1.46M
--0
--0
--906.8K
----
----
Asset deal income
158.46%67.99K
83.41%-25.15K
79.01%-3.61K
117.85%275.98K
-193.17%-116.29K
-214.01%-151.56K
-124.56%-17.21K
123.78%126.69K
218.41%124.81K
1,267.52%132.94K
Other revenue
-30.23%5.29M
2.60%5.72M
-46.78%1.6M
45.10%11.65M
97.82%7.58M
179.22%5.58M
202.17%3M
-23.08%8.03M
-39.34%3.83M
-49.75%2M
Operating profit
4.57%337.19M
5.48%245.22M
4.21%105.52M
0.56%468.56M
-2.66%322.45M
3.73%232.48M
6.53%101.26M
14.80%465.94M
8.50%331.26M
11.55%224.12M
Add:Non operating Income
10.94%1.36M
-4.26%1.12M
44.74%246.55K
-33.82%2.65M
-49.84%1.23M
-39.96%1.17M
-79.99%170.34K
-66.67%4.01M
83.86%2.45M
146.81%1.94M
Less:Non operating expense
409.21%4.75M
81.57%1.18M
7.31%227.06K
-54.66%1.79M
1.25%932.76K
29.82%651.06K
28.10%211.6K
46.46%3.94M
-43.63%921.27K
-59.13%501.52K
Total profit
3.43%333.8M
5.22%245.15M
4.27%105.54M
0.73%469.42M
-3.02%322.74M
3.29%233M
5.72%101.22M
12.23%466.01M
9.10%332.79M
12.51%225.57M
Less:Income tax cost
19.19%75.9M
26.77%54.39M
-2.67%22.02M
-8.79%104.93M
-21.21%63.68M
-23.58%42.9M
-7.32%22.62M
4.01%115.04M
6.41%80.83M
10.05%56.14M
Net profit
-0.45%257.9M
0.35%190.76M
6.26%83.52M
3.85%364.49M
2.82%259.06M
12.20%190.1M
10.19%78.6M
15.22%350.97M
10.00%251.96M
13.35%169.42M
Net profit from continuing operation
-0.45%257.9M
0.35%190.76M
6.26%83.52M
3.85%364.49M
2.82%259.06M
12.20%190.1M
10.19%78.6M
15.22%350.97M
10.00%251.96M
13.35%169.42M
Less:Minority Profit
119.00%554.29K
-63.90%390.67K
80.02%-252.02K
-83.43%964.06K
-365.49%-2.92M
64.19%1.08M
-238.00%-1.26M
562.10%5.82M
135.16%1.1M
118.95%659.13K
Net profit of parent company owners
-1.77%257.35M
0.72%190.37M
4.90%83.78M
5.32%363.53M
4.43%261.98M
12.00%189.01M
11.37%79.86M
12.84%345.16M
8.04%250.86M
10.34%168.76M
Earning per share
Basic earning per share
-1.49%0.66
0.00%0.49
4.76%0.22
5.62%0.94
3.08%0.67
13.95%0.49
16.67%0.21
12.66%0.89
8.33%0.65
10.26%0.43
Diluted earning per share
-1.49%0.66
----
----
----
--0.67
----
----
----
----
----
Other composite income
-105.58%-67.89K
-18.11%1.09M
101.17%5.17K
-69.35%1.02M
-67.86%1.22M
-16.83%1.34M
-58.21%-441.71K
435.34%3.32M
1,234.13%3.78M
528.46%1.61M
Other composite income of parent company owners
-105.58%-67.89K
-18.11%1.09M
101.17%5.17K
-69.35%1.02M
-67.86%1.22M
-16.83%1.34M
-58.21%-441.71K
435.34%3.32M
1,234.13%3.78M
528.46%1.61M
Total composite income
-0.94%257.83M
0.22%191.86M
6.87%83.53M
3.17%365.51M
1.77%260.28M
11.93%191.43M
10.00%78.16M
16.69%354.29M
11.81%255.74M
14.71%171.03M
Total composite income of parent company owners
-2.25%257.28M
0.59%191.47M
5.49%83.78M
4.61%364.55M
3.36%263.19M
11.73%190.35M
11.19%79.42M
14.30%348.48M
9.83%254.64M
11.67%170.37M
Total composite income of minority owners
119.00%554.29K
-63.90%390.67K
80.02%-252.02K
-83.43%964.06K
-365.49%-2.92M
64.19%1.08M
-238.00%-1.26M
562.10%5.82M
135.16%1.1M
118.95%659.13K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 4.32%15.41B2.81%10.31B6.08%5.14B1.97%19.85B3.15%14.78B7.32%10.02B4.40%4.84B10.93%19.46B10.16%14.32B10.22%9.34B
Operating revenue 4.32%15.41B2.81%10.31B6.08%5.14B1.97%19.85B3.15%14.78B7.32%10.02B4.40%4.84B10.93%19.46B10.16%14.32B10.22%9.34B
Other operating revenue -----6.47%24.82M----7.03%60.56M----3.13%26.54M----52.24%56.58M----89.66%25.73M
Total operating cost 4.26%15.05B2.64%10.04B6.07%5.02B2.19%19.36B3.36%14.44B7.54%9.78B4.38%4.73B10.73%18.95B10.16%13.97B10.17%9.1B
Operating cost 4.34%14.28B2.73%9.53B6.22%4.76B2.17%18.34B3.39%13.69B7.68%9.28B4.22%4.48B10.96%17.95B10.30%13.24B10.28%8.62B
Operating tax surcharges 12.99%34.07M17.29%23.29M10.78%11.04M3.04%43.55M2.34%30.16M1.16%19.86M9.95%9.96M7.81%42.26M-3.29%29.47M0.50%19.63M
Operating expense 5.02%341.69M2.79%224.48M8.84%114.82M2.07%441.71M5.03%325.35M7.49%218.38M6.21%105.49M14.09%432.77M9.97%309.78M9.88%203.18M
Administration expense 4.89%234.67M1.79%154.21M3.65%78.01M3.51%309.28M1.33%223.74M4.31%151.49M7.85%75.26M-7.17%298.78M-1.44%220.81M0.19%145.23M
Financial expense -6.99%155.39M-6.81%103.16M-8.91%52.73M1.30%222.91M0.77%167.06M1.58%110.7M8.13%57.89M15.01%220.05M19.33%165.79M19.42%108.97M
-Interest expense (Financial expense) 1.29%152.95M0.27%101.71M-0.47%50.78M1.71%222.85M1.08%151M3.24%101.44M8.70%51.02M15.15%219.1M11.72%149.38M13.22%98.25M
-Interest Income (Financial expense) 17.61%-3.01M44.08%-2.1M16.62%-1.04M-33.27%-5.14M11.67%-3.66M-48.82%-3.75M-34.98%-1.25M25.53%-3.86M17.04%-4.14M-0.52%-2.52M
Research and development 28.23%3.64M41.26%2.74M58.31%1.22M33.47%5.53M-0.77%2.84M38.41%1.94M27.61%769.3K39.51%4.15M24.78%2.86M-16.03%1.4M
Credit Impairment Loss 4.17%-17.52M-35.85%-14.86M-2.20%-12.28M70.15%-14.71M13.57%-18.28M24.51%-10.94M-17.29%-12.02M-57.46%-49.3M-2.77%-21.15M-25.30%-14.49M
Asset Impairment Loss 49.98%-289.95K227.46%418.83K-426.72%-575.39K17.53%-2.58M88.66%-579.62K92.46%-328.6K95.94%-109.24K55.64%-3.13M-30.06%-5.11M2.58%-4.36M
Other net revenue -56.48%-25.44M-140.57%-18.06M-26.33%-14.81M65.76%-17.53M34.44%-16.25M58.61%-7.51M4.32%-11.73M-67.33%-51.19M-41.73%-24.79M-23.70%-18.13M
Fair value change income ----------0--------------0------------
Invest income -167.53%-12.98M-459.42%-9.31M-37.48%-3.55M-75.66%-12.16M-95.55%-4.85M-17.43%-1.66M-577.61%-2.58M-224.12%-6.92M-404.65%-2.48M45.20%-1.42M
Net open hedge income ----------0--------------0------------
-Including: Investment income associates -320.97%-3.22M---2.45M--0-117.01%-154.29K--1.46M--0--0--906.8K--------
Asset deal income 158.46%67.99K83.41%-25.15K79.01%-3.61K117.85%275.98K-193.17%-116.29K-214.01%-151.56K-124.56%-17.21K123.78%126.69K218.41%124.81K1,267.52%132.94K
Other revenue -30.23%5.29M2.60%5.72M-46.78%1.6M45.10%11.65M97.82%7.58M179.22%5.58M202.17%3M-23.08%8.03M-39.34%3.83M-49.75%2M
Operating profit 4.57%337.19M5.48%245.22M4.21%105.52M0.56%468.56M-2.66%322.45M3.73%232.48M6.53%101.26M14.80%465.94M8.50%331.26M11.55%224.12M
Add:Non operating Income 10.94%1.36M-4.26%1.12M44.74%246.55K-33.82%2.65M-49.84%1.23M-39.96%1.17M-79.99%170.34K-66.67%4.01M83.86%2.45M146.81%1.94M
Less:Non operating expense 409.21%4.75M81.57%1.18M7.31%227.06K-54.66%1.79M1.25%932.76K29.82%651.06K28.10%211.6K46.46%3.94M-43.63%921.27K-59.13%501.52K
Total profit 3.43%333.8M5.22%245.15M4.27%105.54M0.73%469.42M-3.02%322.74M3.29%233M5.72%101.22M12.23%466.01M9.10%332.79M12.51%225.57M
Less:Income tax cost 19.19%75.9M26.77%54.39M-2.67%22.02M-8.79%104.93M-21.21%63.68M-23.58%42.9M-7.32%22.62M4.01%115.04M6.41%80.83M10.05%56.14M
Net profit -0.45%257.9M0.35%190.76M6.26%83.52M3.85%364.49M2.82%259.06M12.20%190.1M10.19%78.6M15.22%350.97M10.00%251.96M13.35%169.42M
Net profit from continuing operation -0.45%257.9M0.35%190.76M6.26%83.52M3.85%364.49M2.82%259.06M12.20%190.1M10.19%78.6M15.22%350.97M10.00%251.96M13.35%169.42M
Less:Minority Profit 119.00%554.29K-63.90%390.67K80.02%-252.02K-83.43%964.06K-365.49%-2.92M64.19%1.08M-238.00%-1.26M562.10%5.82M135.16%1.1M118.95%659.13K
Net profit of parent company owners -1.77%257.35M0.72%190.37M4.90%83.78M5.32%363.53M4.43%261.98M12.00%189.01M11.37%79.86M12.84%345.16M8.04%250.86M10.34%168.76M
Earning per share
Basic earning per share -1.49%0.660.00%0.494.76%0.225.62%0.943.08%0.6713.95%0.4916.67%0.2112.66%0.898.33%0.6510.26%0.43
Diluted earning per share -1.49%0.66--------------0.67--------------------
Other composite income -105.58%-67.89K-18.11%1.09M101.17%5.17K-69.35%1.02M-67.86%1.22M-16.83%1.34M-58.21%-441.71K435.34%3.32M1,234.13%3.78M528.46%1.61M
Other composite income of parent company owners -105.58%-67.89K-18.11%1.09M101.17%5.17K-69.35%1.02M-67.86%1.22M-16.83%1.34M-58.21%-441.71K435.34%3.32M1,234.13%3.78M528.46%1.61M
Total composite income -0.94%257.83M0.22%191.86M6.87%83.53M3.17%365.51M1.77%260.28M11.93%191.43M10.00%78.16M16.69%354.29M11.81%255.74M14.71%171.03M
Total composite income of parent company owners -2.25%257.28M0.59%191.47M5.49%83.78M4.61%364.55M3.36%263.19M11.73%190.35M11.19%79.42M14.30%348.48M9.83%254.64M11.67%170.37M
Total composite income of minority owners 119.00%554.29K-63.90%390.67K80.02%-252.02K-83.43%964.06K-365.49%-2.92M64.19%1.08M-238.00%-1.26M562.10%5.82M135.16%1.1M118.95%659.13K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Rong Cheng Certified Public Accountants (Special General Partnership)------Rong Cheng Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Cold Chain Logistics
Cold Chain Logistics
Intraday-1.82%
Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday-1.88%